Home
Dr Reddys Laboratories Ltd Share Holding Pattern
Promoters Holdings Over Time
Key Highlights
- Mutual funds increased their stake in the company by 2.10% from March 2024 to June 2024.
- Promoters decreased their stake in the company by 0.00% from March 2024 to June 2024. FIIs/FPIs decreased their stake in the company by 1.46% from March 2024 to June 2024.
Latest Shareholding
Market Price of Dr Reddys Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Dr Reddys Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
Last Ten Days Market Price
| Date |  Price (₹) |
|---|---|
| 21 Feb 2025 | 1151.95 |
| 20 Feb 2025 | 1170.9 |
| 19 Feb 2025 | 1164.7 |
| 18 Feb 2025 | 1197.85 |
| 17 Feb 2025 | 1199.75 |
| 14 Feb 2025 | 1195.85 |
| 13 Feb 2025 | 1223.3 |
| 12 Feb 2025 | 1215.9 |
| 11 Feb 2025 | 1211.8 |
| 10 Feb 2025 | 1220.85 |
Dr Reddys Laboratories Ltd News Hub
Dr Reddys Laboratories Ltd gains for third straight session
Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707
Read more
21 Aug 24
Dr Reddy's formulations manufacturing units receives EIR from USFDA
Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m
Read more
12 Aug 24
Dr Reddys allots 29,790 equity shares under ESOP
Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu
Read more
07 Aug 24
Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
06 Sept 24
Document
Annual Reports
Annual Report 2024
Credit Ratings
N/A
Concalls
Aug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptAug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptPopular Search
FAQs for Share Holding Pattern of Dr Reddys Laboratories Ltd
On what factors does the shareholding pattern of Dr Reddys Laboratories Ltd change frequently?
The shareholding pattern of Dr Reddys Laboratories Ltd can change due to various factors such as stock market transactions, new share issuances, buy-backs, or changes in ownership by institutional and retail investors.
How often is Dr Reddys Laboratories Ltd's shareholding pattern updated?
The Dr Reddys Laboratories Ltd shareholding pattern is typically updated quarterly or semi-annually, depending on regulatory requirements and internal reporting schedules.
What categories are included in the shareholding pattern of Dr Reddys Laboratories Ltd?
Categories included in the shareholding pattern of Dr Reddys Laboratories Ltd include promoter/management holdings, institutional investors, retail investors, and others such as foreign investors.
Why is the shareholding pattern of Dr Reddys Laboratories Ltd important for investors?
The shareholding pattern of Dr Reddys Laboratories Ltd is important for investors as it provides insights into ownership distribution, control dynamics, and the potential influence of major shareholders on company decisions and stock performance.
Where can I find the latest shareholding pattern of Dr Reddys Laboratories Ltd?
The latest shareholding pattern of Dr Reddys Laboratories Ltd can be found on BlinkX. You may also check the quarterly financial reports, which are available on the company’s official website under the Investor Relations section. Additionally, you can check stock exchange websites like NSE and BSE for the most recent filings.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
